{"filing":{"accession_number":"0001104659-26-109824","cik":"0001735438","ticker":"MGTX","company_name":"MeiraGTx Holdings plc","form":"8-K","filing_date":"2026-09-23","report_date":"2026-09-22","primary_document":"mgtx-20260922x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/mgtx-20260922x8k.htm"},"events":[{"id":34494,"run_id":31740,"accession_number":"0001104659-26-109824","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Alan M. Sebulsky was appointed to the Board of Directors as a Class I director effective September 23, 2026, bringing 40+ years of healthcare investment and biopharmaceutical portfolio management experience, including prior board service at Jazz Pharmaceuticals and Arrow International.","company_name":"MeiraGTx Holdings plc","ticker":"MGTX","filing_date":"2026-09-23","form":"8-K","submitted_at":null,"items":[{"id":38233,"accession_number":"0001104659-26-109824","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Alan M. Sebulsky to the Board of Directors as a Class I director, effective September 23, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The principal disclosed action is a person taking a role (board director appointment), not a departure. Sebulsky's extensive 40+ years of healthcare investment and biopharmaceutical portfolio management experience, combined with his prior board service at Jazz Pharmaceuticals and Arrow International, makes this a material governance event affecting the composition and expertise of the board.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:13:42.153161+00:00","company_name":"","ticker":null,"filing_date":""},{"id":38234,"accession_number":"0001104659-26-109824","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Alan M. Sebulsky to MeiraGTx's Board of Directors, announced via press release on September 23, 2026. Sebulsky brings 40+ years of healthcare investment and board experience, including prior service on boards of publicly traded companies (Jazz Pharmaceuticals, Arrow International) and current portfolio management roles. Board appointments of experienced executives are material governance events affecting investor assessment of company leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:13:42.153161+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38233,"accession_number":"0001104659-26-109824","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Alan M. Sebulsky to the Board of Directors as a Class I director, effective September 23, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The principal disclosed action is a person taking a role (board director appointment), not a departure. Sebulsky's extensive 40+ years of healthcare investment and biopharmaceutical portfolio management experience, combined with his prior board service at Jazz Pharmaceuticals and Arrow International, makes this a material governance event affecting the composition and expertise of the board.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:13:42.153161+00:00","company_name":"MeiraGTx Holdings plc","ticker":"MGTX","filing_date":"2026-09-23"},{"id":38234,"accession_number":"0001104659-26-109824","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Alan M. Sebulsky to MeiraGTx's Board of Directors, announced via press release on September 23, 2026. Sebulsky brings 40+ years of healthcare investment and board experience, including prior service on boards of publicly traded companies (Jazz Pharmaceuticals, Arrow International) and current portfolio management roles. Board appointments of experienced executives are material governance events affecting investor assessment of company leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T12:13:42.153161+00:00","company_name":"MeiraGTx Holdings plc","ticker":"MGTX","filing_date":"2026-09-23"}]}